internal iliac artery and outflow via dilated veins of the perispinal plexus (Fig. 1) . The feeding arteries were selectively and completely embolized using embospheres and gelfoam. The patient was taken to surgery the day after embolization to undergo resection of the hemangioblastoma.
Operation. The patient was placed prone, and electromyographic electrodes were placed in the pelvic floor, external urinary sphincter, and anal sphincter. Intravesicular pressure monitoring was used to evaluate for detrusor contraction. A partial L-5 and complete S1-3 laminectomies were performed to provide wide bloodless exposure 1 cm above and below the rostral and caudal margins of the tumor. The S-1 and S-3 nerve roots were identified and isolated from the tumor and the S-2 nerve root from which the tumor originated. The embolized tumor was incised posteriorly and partially debulked with an ultrasonic aspirator. Vessels entering and leaving the tumor capsule were coagulated using bipolar cautery and sharply divided. After stimulation indicated no evidence of motor function in the involved nerve root, the proximal (intradural) and distal (foraminal) ends of the left S-2 nerve root were transected and the remaining tumor was removed. The distal end of the S-2 root was coagulated and the sleeve of the dura around the proximal end of the S-2 root was closed in a watertight fashion. The muscular and cutaneous layers were closed anatomically. Blood loss was less than 100 ml.
Postoperative Course. The patient's postoperative course was uncomplicated. Her back and lower-extremity pain resolved. At 1-year follow-up examination, her left S-1 numbness had resolved, and she has residual left S-2 dermatomal numbness.
DISCUSSION
von Hippel-Lindau Disease von Hippel-Lindau disease is an autosomal-dominant neoplasia syndrome (MIM 193300) that is the result of a germline mutation or deletion in the von Hippel-Lindau syndrome gene on the short arm of chromosome 3.
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Germline mutations in the this gene can result in the development of a number of benign or malignant tumors and cysts in multiple organ systems. 12 Affected individuals may develop visceral lesions including renal cysts and carcinomas, pheochromocytomas, pancreatic cysts, and neuroendocrine tumors, as well as epididymal and broad ligament cystadenomas. Central nervous system manifestations include retinal, supratentorial, cerebellar, brainstem, and spinal cord hemangioblastomas, as well as endolymphatic sac tumors.
Hemangioblastomas of the CNS are the most common tumor in von Hippel-Lindau disease and can be found in 60 to 80% of all patients with the disease. 5, 12, 18, 23 The overall mean age at presentation for CNS hemangioblastomas in von Hippel-Lindau disease is 33 years. 23 The most common locations for CNS hemangioblastomas are the cerebellum (44-72%) and the spinal cord (13-50%), followed by the brainstem (10-20%), supratentorial region (Ͻ 1%), and lumbosacral nerve roots (Ͻ 1%). 6, 10, 12, 14, 15, 19, 20, 23, 24 Although the incidence of lumbosacral nerve root hemangioblastomas is very low in our experience (Ͼ 1500 CNS hemangioblastomas evaluated in patients with von Hippel-Lindau disease), we recommend that neuroimaging of the lumbosacral region be performed in patients with von Hippel-Lindau disease with referable (to this anatomical region) signs or symptoms.
13

Previous Cases
There are two previously reported cases of sacral nerve root hemangioblastomas. In the first report, Chu, et al., 2 describe a 24-year-old woman with a von Hippel-Lindau disease-associated S-1 hemangioblastoma (Table 1) who presented with left-sided foot pain. The hemangioblastoma was evident on contrast-enhanced MR imaging, and arteriography revealed that the tumor was supplied via feeding arteries from the internal iliac artery. These feeding vessels were embolized, and the patient underwent complete resection of the hemangioblastoma and associated nerve root. The intraoperative findings and clinical outcome in this patient were not reported. In a report by Hermier, et al., 8 the authors described a 58-year-old man with a sporadic S-1 hemangioblastoma (Table 1) who present-R. M. Pluta, et al. ed with a 2-year history of progressive low-back pain, bilateral leg pain, and dysuria. The hemangioblastoma was evident on contrast-enhanced computerized tomography and MR imaging. Arteriography revealed large feeding vessels from the sacral artery. These feeding vessels were embolized, and the patient underwent complete resection of the hemangioblastoma and associated nerve root. Postoperatively, rapid clinical improvement was demonstrated, including resolution of leg pain and weakness, as well as improvement in dysuria.
Present Case
Associated Symptoms. Similar to the two previous reports of sacral hemangioblastomas (Table 1) , our patient presented with back and lower-extremity pain. Similar to reports of patients with lumbar nerve root hemangioblastomas, 13 our patient also experienced dermatomal numbness in the left S-1 and S-2 distribution. The symptomatology in this case was likely due to direct nerve root (S-2) involvement and adjacent (S-1) nerve root compression by the hemangioblastoma.
Imaging Findings. Contrast-enhanced T 1 -weighted MR imaging of the lumbosacral spine revealed the hemangioblastoma to be a contrast-enhancing mass eroding the sacrum (Fig. 1) . Vivid contrast enhancement is characteristic of hemangioblastomas throughout the CNS. Consistent with the highly vascular nature of hemangioblastomas, flow voids can often be seen within large tumors.
2,13
Intraoperative Findings. Intraoperative monitoring of the hemangioblastoma-involved nerve root may be helpful in defining its function and can assist in determining the feasibility of nerve root sacrifice. If the hemangioblastoma-associated nerve root is a motor root, then intradural exploration with or without debulking may be the best option. We previously reported on a patient with two cauda equina hemangioblastomas, each involving lumbar motor roots. 13 Dissection of these hemangioblastomas from the motor roots was impossible because of intrafascicular involvement and because nerve root resection would have caused an unacceptable deficit, these lesions were not resected and the patient's symptoms have remained stable. 13 That these hemangioblastomas have not grown and that symptoms have stabilized underscore the findings of Wanebo, et al., 23 in which von Hippel-Lindau disease-associated hemangioblastomas were often found to have long periods of arrested growth associated with no further progression of symptoms, thus allowing for the determination of the feasibility of adjuvant treatments such as irradiation. Selective arteriography followed by embolization proved useful for minimizing blood loss during resection of this large sacral hemangioblastoma. We do not, however, routinely perform arteriography and embolization in a case of CNS hemangioblastomas. Generally, hemangioblastomas in the CNS can be excised in a near bloodless fashion by performing circumferential microdissection outside of the tumor capsule, thus avoiding embolization and its complications, including vessel rupture and inadvertent occlusion of brain or spinal cord nutrient vessels.
12,13
Histopathological Findings. Histopathological examination in the present case confirmed the diagnosis of hemangioblastoma. The tumor displayed a highly vascular capillary plexus surrounded by morphologically bland, vacuolated stromal cells typical of hemangioblastoma (Fig. 2) . Intrafascicular infiltration of the S-2 nerve root was also seen (Fig. 2) . This is consistent with previous autopsy findings reported by Ismail, et al., 9 and our previous experience 13 with cauda equina hemangioblastomas involving the intrafascicular growth of these tumors. Subsequently, the presence of intrafascicular tumor requires sacrifice of the nerve root to achieve complete resection.
Outcome. The numbness and pain in the left S-1 dermatome, which was likely caused by S-2 hemangioblastoma-induced compression of the S-1 nerve root, resolved immediately postoperatively. The patient experiences residual numbness in the S-2 dermatome attributable to the hemangioblastoma-infiltrated nerve root that was resected. This is consistent with the previous reports in which stabilization or improvement in symptoms occurred after resection of lumbar nerve root hemangioblastomas. 1, 4, 7, 13, 16, 17, 21, 22 CONCLUSIONS Sacral nerve root hemangioblastomas may be safely removed. Generally, hemangioblastomas of the sacral nerve roots should be excised when they become symptomatic. Because it appears that these neoplasms originate from the nerve root (similar to lumbar nerve root hemangioblastomas), it is necessary to sacrifice the nerve root from which the lesion originates to achieve complete resection.
